BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3309954)

  • 1. A critical evaluation of the use of androgen receptor assays to predict the androgen responsiveness of prostatic cancer.
    Barrack ER; Tindall DJ
    Prog Clin Biol Res; 1987; 239():155-87. PubMed ID: 3309954
    [No Abstract]   [Full Text] [Related]  

  • 2. Endocrine therapy: predictors of response to prostatic cancer.
    Geller J; Albert JD
    Semin Urol; 1983 Nov; 1(4):291-7. PubMed ID: 6399615
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hormonal receptors and other procedures for predicting clinical response in cancer of the prostate].
    Habib FK; Chisholm GD
    Arch Esp Urol; 1984 Dec; 37 Suppl 2():751-9. PubMed ID: 6085672
    [No Abstract]   [Full Text] [Related]  

  • 4. Steroid receptor and biochemical profiles in prostatic cancer: correlation with response to hormonal treatment.
    Barrack ER; Brendler CB; Walsh PC
    Prog Clin Biol Res; 1987; 243A():79-97. PubMed ID: 3309976
    [No Abstract]   [Full Text] [Related]  

  • 5. Uses and limitations of hormone, receptor and enzyme assays in prostate cancer.
    Martin PM; Le Goff JM; Brisset JM; Ojasoo T; Husson JM; Raynaud JP
    Prog Clin Biol Res; 1987; 243A():111-40. PubMed ID: 3309969
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recent findings on androgen receptors].
    Shimazaki J; Kodama T
    Nihon Rinsho; 1981 Sep; 39(9):2999-3004. PubMed ID: 6175780
    [No Abstract]   [Full Text] [Related]  

  • 7. The relationship of androgen receptor levels to androgen responsiveness in the Dunning R3327 rat prostate tumor sublines.
    Diamond DA; Barrack ER
    J Urol; 1984 Oct; 132(4):821-7. PubMed ID: 6471235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibition by diethylstilbestrol and relapse of the Noble rat prostatic tumor.
    Wakisaka M; Drury RE; Kadohama N
    Hinyokika Kiyo; 1988 Jan; 34(1):107-15. PubMed ID: 3376790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Punch biopsy tissue: enzyme and receptor analyses as criteria for hormone responsiveness in the treatment of prostatic cancer--limitations.
    Bartsch G; Janetschek G; Daxenbichler G; Dietze O; Mikuz G
    Prog Clin Biol Res; 1987; 243A():101-10. PubMed ID: 3658997
    [No Abstract]   [Full Text] [Related]  

  • 10. Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptors.
    Barrack ER; Bujnovszky P; Walsh PC
    Cancer Res; 1983 Mar; 43(3):1107-16. PubMed ID: 6186370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptor sites: genomic sites for androgenic regulation of prostatic growth.
    Rennie PS
    Prog Clin Biol Res; 1987; 239():189-203. PubMed ID: 3309955
    [No Abstract]   [Full Text] [Related]  

  • 12. [Importance of determining steroid hormone receptors and the treatment of prostatic cancer].
    Fedotov IA; Denisov LE; Kozlov VP; Degtiar' VG
    Urol Nefrol (Mosk); 1983; (1):63-70. PubMed ID: 6187115
    [No Abstract]   [Full Text] [Related]  

  • 13. Androgen receptor assays in advanced prostatic cancer.
    Buttyan R; Olsson CA
    Urol Clin North Am; 1984 May; 11(2):311-7. PubMed ID: 6375068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear and cytosol androgen receptor in androgen dependent dermatoses in female patients.
    Schmidt JB
    Exp Clin Endocrinol; 1987 Aug; 90(1):107-12. PubMed ID: 2959494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytoplasmic androgen receptors in biopsy specimens of prostatic tumors].
    Kushlinskiĭ NE; Degtiar' VG; Bassalyk LS
    Lab Delo; 1983; (7):18-20. PubMed ID: 6194344
    [No Abstract]   [Full Text] [Related]  

  • 16. [A study of correlations between therapeutic efficacy of anti-androgen therapy in prostatic cancer and androgen receptor content of prostatic cancer tissue].
    Ohno K; Umehara T; Kumamoto Y
    Nihon Hinyokika Gakkai Zasshi; 1984 Aug; 75(8):1212-24. PubMed ID: 6513222
    [No Abstract]   [Full Text] [Related]  

  • 17. The androgen receptor and mechanisms for androgen independence in prostate cancer.
    Javidan J; Deitch AD; Shi XB; de Vere White RW
    Cancer Invest; 2005; 23(6):520-8. PubMed ID: 16203660
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation between clinical response to hormone therapy and steroid receptor content in prostatic cancer.
    Gustafsson JA; Ekman P; Snochowski M; Zetterberg A; Pousette A; Högberg B
    Cancer Res; 1978 Nov; 38(11 Pt 2):4345-8. PubMed ID: 698975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods for the determination of androgen receptor content in human prostatic tissue.
    Trachtenberg J; Hicks LL; Walsh PC
    Invest Urol; 1981 Mar; 18(5):349-54. PubMed ID: 7203958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor assay in small biopsies of human prostate. Preservation of nuclear receptor from rat ventral prostate by lyophilization.
    de Larminat MA; Scorticati C; Rennie PS; Bruchovsky N
    Prog Clin Biol Res; 1984; 142():247-59. PubMed ID: 6200889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.